LEADER 03978oam 2200925I 450 001 9910162789303321 005 20240505192201.0 010 $a1-317-42694-0 010 $a1-315-69038-1 010 $a1-317-42695-9 024 7 $a10.4324/9781315690384 035 $a(CKB)3710000001042707 035 $a(MiAaPQ)EBC4793247 035 $a(OCoLC)970693736 035 $a(EXLCZ)993710000001042707 100 $a20180706d2017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aEuropean drug policies $ethe ways of reform /$fedited by Renaud Colson and Henri Bergeron 205 $a1st ed. 210 1$aAbingdon, Oxon ;$aNew York :$cRoutledge,$d2017. 215 $a1 online resource (xx, 314 pages) 300 $aDescription based on print version record. 311 $a1-138-91520-3 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $apt. 1. Regional dimension of European drug policies -- pt. 2. Domestic drug policies in Europe -- pt. 3. Trends and prospects in European drug policies. 330 $aThe drug control regime established by the international community has not succeeded in curbing either the demand for, or the offer of, narcotics. But, despite a series of developments in the Americas ? including the legalisation of cannabis in Uruguay and in several states in the United States of America ? there is still little support in Europe for repealing drug-prohibition laws. Nevertheless, a gradual policy convergence reveals the emergence of a European model favouring public-health strategies over a strictly penal approach to combatting drugs, while growing transnational support for legalisation indicates the persistence of an alternative paradigm for drug policy. This book examines the various influences on drug policies in Europe, as grassroots movements, NGO networks, private foundations and academic research centres increasingly confront the prevailing discourses of drug prohibition. Pursuing an interdisciplinary approach and bringing together legal scholars, social scientists and practitioners, it provides a comprehensive and critical assessment of drug policy reform in Europe. 606 $aDrug control$zEurope 606 $aNarcotic laws$zEurope 606 $aDrugs of abuse$zEurope 606 $aEuropean Monitoring Centre for Drugs and Drug Addiction$9eng$2eurovoc 606 $adrug surveillance$9eng$2eurovoc 606 $acase study$9eng$2eurovoc 606 $aBelgium$9eng$2eurovoc 606 $aDenmark$9eng$2eurovoc 606 $aFrance$9eng$2eurovoc 606 $aGermany$9eng$2eurovoc 606 $aItaly$9eng$2eurovoc 606 $aNetherlands$9eng$2eurovoc 606 $aPoland$9eng$2eurovoc 606 $aSpain$9eng$2eurovoc 606 $aSweden$9eng$2eurovoc 606 $aSwitzerland$9eng$2eurovoc 606 $aUnited Kingdom$9eng$2eurovoc 606 $aEU law$9eng$2eurovoc 606 $anational law$9eng$2eurovoc 615 0$aDrug control 615 0$aNarcotic laws 615 0$aDrugs of abuse 615 7$aEuropean Monitoring Centre for Drugs and Drug Addiction 615 7$adrug surveillance 615 7$acase study 615 7$aBelgium 615 7$aDenmark 615 7$aFrance 615 7$aGermany 615 7$aItaly 615 7$aNetherlands 615 7$aPoland 615 7$aSpain 615 7$aSweden 615 7$aSwitzerland 615 7$aUnited Kingdom 615 7$aEU law 615 7$anational law 676 $a364.1/77094 676 $a364.177094 686 $a28.12.10$2EP-CLASS 701 $aBergeron$b Henri$0972329 701 $aColson$b Renaud$0972330 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910162789303321 996 $aEuropean drug policies$92210857 997 $aUNINA